Alterity Therapeutics Files Application for Quotation of Securities

On September 1, 2026, Alterity Therapeutics Limited filed a Form 6-K with the Securities and Exchange Commission to report an application for the quotation of securities. The filing includes Exhibit 99.1, which specifically pertains to an 'Application for quotation of securities - ATH.' This administrative filing indicates the company is seeking to list or quote additional securities on the relevant exchange. The document was signed by Julian Babarczy, the Chairman of the Board. As a development-stage enterprise, such applications are common for managing equity and capital structure. The filing also notes that the information is being incorporated by reference into several existing Registration Statements on Form S-8 and Form F-3, which typically relate to employee benefit plans and shelf registrations for future capital raises. No specific financial terms, share volumes, or pricing details were disclosed in the summary text of the report.